[HTML][HTML] Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

DG Chen, J Xie, J Choi, RH Ng, R Zhang, S Li… - Cell Reports, 2024 - cell.com
Infection, autoimmunity, and cancer are principal human health challenges of the 21 st
century. Often regarded as distinct ends of the immunological spectrum, recent studies hint …

How to and should we target EBV in MS?

S Eckert, D Jakimovski, R Zivadinov… - Expert Review of …, 2024 - Taylor & Francis
Introduction The etiology of multiple sclerosis (MS) remains unknown. Pathogenesis likely
relies on a complex interaction between multiple environmental, genetic, and behavioral risk …

Natural killer cells that target autoimmune cells linked with protection against multiple sclerosis

Y Bordon - Nature Reviews Immunology, 2024 - nature.com
Natural killer cells that target autoimmune cells linked with protection against multiple
sclerosis | Nature Reviews Immunology Skip to main content Thank you for visiting nature.com …

The expanding clinical and genetic spectrum of DYNC1H1-related disorders

B Möller, LL Becker, A Saffari, A Afenjar, EG Coci… - Brain, 2024 - academic.oup.com
Intracellular trafficking involves an intricate machinery of motor complexes including the
dynein complex to shuttle cargo for autophagolysosomal degradation. Deficiency in dynein …

Navigating Epstein–Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis

C Xie, C Sun, MS Zeng - Signal Transduction and Targeted Therapy, 2024 - nature.com
In a recent study published in Cell, Vietzen and colleagues discovered the novel role of
natural killer (NK) cells and EBV-specific CD8+ T cell response in controlling EBV-inducing …

Shared genetic architecture between autoimmune disorders and B-cell acute lymphoblastic leukemia: insights from large-scale genome-wide cross-trait analysis

X Yu, Y Chen, J Chen, Y Fan, H Lu, D Wu, Y Xu - BMC medicine, 2024 - Springer
Background To study the shared genetic structure between autoimmune diseases and B-cell
acute lymphoblastic leukemia (B-ALL) and identify the shared risk loci and genes and …

Antibody signatures against viruses and microbiome reflect past and chronic exposures and associate with aging and inflammation

S Andreu-Sánchez, A Ripoll-Cladellas, A Culinscaia… - Iscience, 2024 - cell.com
Encounters with pathogens and other molecules can imprint long-lasting effects on our
immune system, influencing future physiological outcomes. Given the wide range of …

Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis

G Abbadessa, MT Lepore, S Bruzzaniti… - Neurology …, 2024 - AAN Enterprises
Background and Objectives The role of B cells in the pathogenic events leading to relapsing
multiple sclerosis (R-MS) has only been recently elucidated. A pivotal step in defining this …

Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders

A Bauer, H Hegen, M Reindl - Expert Review of Molecular …, 2024 - Taylor & Francis
Introduction Body fluid markers could be helpful to predict the conversion into clinically
definite multiple sclerosis (MS) in people with a first demyelinating event of the central …

Genetic and early life factors influence on time-to-multiple sclerosis diagnosis: A UK Biobank study

A Nova, G Di Caprio, L Bernardinelli… - Multiple Sclerosis …, 2024 - journals.sagepub.com
Background: Previous investigations into multiple sclerosis (MS) risk factors predominantly
relied on retrospective studies, which do not consider different follow-up times and assume a …